allogeneic

Altogether, 16 consecutive patients with MF/SS (MF 10, SS 6) received an alloHCT after TBI/fludarabine-based conditioning as institutional treatment standard between April 2014 and February 2025. Median age at transplantation …

In allogeneic stem cell transplantation (ASCT), antibiotic treatment of neutropenic and organ infections is widely used and needed: Blood stream infections (BSI) account for the most severe manifestations and occur …

Bangham CRM. HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma. Blood. 2023;141:2299–2306. Google Scholar Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. …

Allogeneic hematopoietic stem cell transplantation (HSCT) is considered standard of care in eligible patients with acute myeloid leukemia (AML) and intermediate or adverse risk in first complete remission (CR) as …

Trial design This study will be a controlled, randomized clinical trial with an intervention period of 3 weeks (Fig. 1). The trial was registered at the Iranian Registry of Clinical Trials …

Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. …

Kharfan-Dabaja MA, Kumar A, Ayala E, Aljulf M, Nishibori T, Marsh R, et al. Standardization of definitions of hematopoietic recovery, graft rejection, graft failure, graft dysfunction, and donor chimerism in …

Guglielmelli P, Lasho TL, Rotunno G, Mudireddy M, Mannarelli C, Nicolosi M, et al. MIPSS70: mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis. J Clin Oncol. 2018;36:310–8. …